Efficacy and tolerability of citalopram in the treatment of late-life anxiety disorders: Results from an 8-week randomized, placebo-controlled trial

American Journal of Psychiatry

Volumn 162, Issue 1, 2005, Pages 146-150

  Lenze, Eric J ^a,b   Mulsant, Benoit H ^a   Shear, M Katherine ^a   Dew, Mary Amanda ^a   Miller, Mark D ^a   Pollock, Bruce G ^a   Houck, Patricia ^a   Tracey, Barbara ^a   Reynolds III, Charles F ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; LORAZEPAM; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CHI SQUARE TEST; CLINICAL ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG TOLERABILITY; FATIGUE; FEMALE; HAMILTON SCALE; HUMAN; MALE; NAUSEA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SEDATION; SIDE EFFECT; STATISTICAL MODEL; TREATMENT OUTCOME; XEROSTOMIA;

AGE FACTORS; AGED; ANXIETY DISORDERS; CITALOPRAM; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PLACEBOS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 11844275258     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.1.146     Document Type: Article

References (36)

1. Lindesay J, Briggs K, Murphy E: The Guy's/Age Concern survey: prevalence rates of cognitive impairment, depression and anxiety in an urban elderly community. Br J Psychiatry 1989; 155:317-329
2. Manela M, Katona C, Livingston G: How common are the anxiety disorders in old age? Int J Geriatr Psychiatry 1996; 11:65-70
3. Beekman A, Bremmer MA, Deeg D, Van Balkom A, Smit J, DeBeurs E, Vandyck R, van Tilburg W: Anxiety disorders in later life: a report from the Longitudinal Aging Study Amsterdam. Int J Geriatr Psychiatry 1998; 13:717-726
4. Uhlenhuth EH, Baiter MB, Mellinger GD, Cisin IH, Clinthorne J: Symptom checklist syndromes in the general population: correlations with psychotherapeutic drug use. Arch Gen Psychiatry 1983; 40:1167-1173
5. de Beurs E, Beekman ATF, van Balkom AJLM, Deeg DJH, Van Dyck R, van Tilburg W: Consequences of anxiety in older persons: its effect on disability, well-being and use of health services. Psychol Med 1999; 29:583-593
6. Astrom M: Generalized anxiety disorder in stroke patients: a 3-year longitudinal study. Stroke 1996; 27:270-275
7. Harman JS, Rollman BL, Hanusa BH, Lenze EJ, Shear MK: Physician office visits of adults for anxiety disorders in the United States: 1985-1998. J Gen Intern Med 2002; 17:165-172
8. Harman JS, Mulsant BH, Kelleher KJ, Schulberg HC, Kupfer DJ, Reynolds CF III: Narrowing the gap in treatment of depression. Int J Psychiatry Med 2001; 31:239-253
9. Koepke HH, Gold RL, Linden ME, Lion JR, Rickels K: Multicenter controlled study of oxazepam in anxious elderly outpatients. Psychosomatics 1982; 23:641-645
10. Bohm C, Robinson DS, Gammans RE, Shrotriya RC, Alms DR, Leroy A, Placchi M: Buspirone therapy in anxious elderly patients: a controlled clinical trial. J Clin Psychopharmacol 1990; 10(3 suppl):47S-51S
11. Ray WA, Griffin MR, Downey W: Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 1989; 262:3303-3307
12. Salzman C, Fisher J, Nobel K, Glassman R, Wolfson A, Kelley M: Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents. Int J Geriatr Psychiatry 1992; 7:89-93
13. Herings RMC, Stricker BHC, deBoer A, Bakker A, Sturmans F: Benzodiazepines and the risk of falling leading to femur fractures. Arch Intern Med 1995; 155:1801-1807
14. Liu BA, Topper AK, Reeves RA, Gryfe C, Maki BE: Falls among older people: relationship to medication use and orthostatic hypotension. J Am Geriatr Soc 1995; 43:1141-1145
15. Hemmelgarn B, Suissa S, Huang A, Boivin J-F, Pinard G: Benzodiazepine use and the risk of motor vehicle crash in the elderly. JAMA 1997; 278:27-31
16. Hanlon JT, Horner RD, Schmader KE, Fillenbaum GG, Lewis IK, Wall WE, Landerman LR, Pieper CF, Blazer DG, Cohen HJ: Benzodiazepine use and cognitive function among community-dwelling elderly. Clin Pharmacol Ther 1998; 64:684-692
17. Pomara N, Tun H, DaSilva D, Hernando R, Deptula D, Greenblatt DJ: The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation. Psychopharmacol Bull 1998; 34:139-153
18. Davidson J, Bose A, Su G: Escitalopram in the treatment of generalized anxiety disorder, in Proceedings of the XII World Congress of Psychiatry. New York, World Psychiatric Association, 2002
19. Casacalenda N, Boulenger JP: Pharmacologic treatments effective in both generalized anxiety disorder and major depressive disorder: clinical and theoretical implications. Can J Psychiatry 1998; 43:722-730
20. Wylie ME, Miller MD, Shear MK, Little JT, Mulsant BH, Pollock BG, Reynolds CF III: Fluvoxamine pharmacotherapy of anxiety disorders in later life: preliminary open-trial data. J Geriatr Psychiatry Neurol 2000; 13:43-48
21. Lenze EJ, Mulsant BH, Dew MA, Shear MK, Houck P, Pollock BG, Reynolds CF III: Good treatment outcomes in late-life depression with comorbid anxiety. J Affect Disord 2003; 77:247-254
22. Mulsant BH, Reynolds CF III, Shear MK, Sweet RA, Miller M: Comorbid anxiety disorders in late-life depression. Anxiety 1996; 2:242-247
23. Mulsant BH, Alexopoulos GS, Reynolds CF III, Katz IR, Abrams R, Oslin D, Schulberg HC: Pharmacologic treatment of depression in older primary care patients: the PROSPECT algorithm. Int J Geriatr Psychiatry 2001; 16:585-592
24. Hamilton M: The assessment of anxiety states by rating. Br J Med Psychol 1959; 32:50-55
25. Shear MK, Vander Bilt J, Rucci P, Endicott J, Lydiard B, Otto MW, Pollack MH, Chandler L, Williams J, Ali A, Frank DM: Reliability and validity of a structured interview guide for the Hamilton Anxiety Rating Scale (SIGH-A). Depress Anxiety 2001; 13:166-178
26. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
27. Folstein MF, Folstein SE, McHugh PR: "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198
28. Fillenbaum GG: Multidimensional Functional Assessment of Older Adults: The Duke Older Americans Resources and Services Procedures. Hillsdale, NJ, Lawrence Erlbaum Associates, 1988
29. Gleason PP, Schulz R, Smith NL, Newsom JT, Kroboth PD, Kroboth FJ, Psaty BM: Correlates and prevalence of benzodiazepine use in community-dwelling elderly. J Gen Intern Med 1998; 13:243-250
30. van Balkom AJ, Beekman AT, de Beurs E, Deeg DJ, Van Dyck R, van Tilburg W: Comorbidity of the anxiety disorders in a community-based older population in the Netherlands. Acta Psychiatr Scand 2000; 101:37-45
31. Miller MD, Frank E, Reynolds CF III: The art of clinical management in pharmacologic trials with depressed elderly patients: lessons from the Pittsburgh Study of Maintenance Therapies in Late-Life Depression. Am J Geriatr Psychiatry 1999; 7:228-234
32. Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K: The UKU Side Effect Rating Scale: a new comprehensive rating scale for psychotropic drugs and cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987; 334:1-100
33. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719-748
34. Cohen J: Statistical Power Analysis for the Behavioral Sciences, 2nd ed. Hillsdale, NJ, Lawrence Erlbaum Associates, 1988
35. Katz IR, Reynolds CF III, Alexopoulos GS, Hackett D: Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials. J Am Geriatr Soc 2002; 50:18-25
36. Kraemer HC, Wilson T, Fairburn CG, Agras WS: Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry 2002; 59:877-883